The current drug shortage of ketamine has left many medical offices and ketamine clinics without a way to meet patient needs for this important therapy. Innovation Compounding is pleased to announce that its compounding pharmacy can fulfill the prescriptive needs for IV infusion administration until manufacturers are able to produce.
Now Available to Order
- Ketamine Injection, 50 mg/mL Preserved in 10mL (MDV) Amber Vial
Our Doctor of Pharmacy Clinical Team has the expertise and resources to formulate ketamine injection solutions in 10mL vial sizes.
If you have questions about the professional administration of ketamine or would like to place an order for your practice, please connect with us today!
Connect with Us
If you have any questions or would like additional information, please contact Innovation Compounding at 1-800-547-1399, Monday-Friday, 9 a.m. to 5 p.m. EST, excluding all major holidays.
Medical Disclaimer This content is for informational and educational purposes only. It is not intended to provide medical advice or take the place of such information or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Neither Innovation Compounding, Inc. nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All viewers of this content, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any medication, nutritional supplement, diet, or health regimen. Innovation Compounding does not make or intend to make any claims to efficacy or safety of compounded products for specific conditions or disease states, as compounded products are not FDA-approved for these conditions.
Sources & References
“Compounding Pharmacies Market Share: Statistics Report 2027.” Global Market Insights Inc.,
Lianna Matt McLernon | News Writer | CIDRAP News | Jul 27, 2021. “Drug Compounding
Helped Address Drug Gaps during COVID.” CIDRAP, 27 July 2021,
Staff. “Compounding Pharmacies Step into the Breach Created by the Coronavirus Pandemic.”
U.S. Pharmacist – The Leading Journal in Pharmacy, 15 May 2020,